SELECT+

Welcome to the Brand page for “SELECT+”, which is offered here for Chemoselective agents for gene therapy, for the treatment or prevention of diseases affecting the immune system or hematologic system;.

Its status is currently believed to be active. Its class is unavailable. “SELECT+” is believed to be currently owned by “CSL BEHRING GENE THERAPY, INC.”

Owner:
CSL BEHRING GENE THERAPY, INC.
Owner Details
Description:
Chemoselective agents for gene therapy, for the treatment or prevention of diseases affecting the immune system or hematologic system;
Categories: CHEMOSELECTIVE AGENTS GENE THERAPY